Meds UK Limited - Period Ending 2018-03-13

Meds UK Limited - Period Ending 2018-03-13


Meds UK Limited 06998843 false 2017-05-01 2018-03-13 2018-03-13 The principal activity of the company is that of a retail pharmacy. Digita Accounts Production Advanced 6.21.8540.0 Software true true false 06998843 2017-05-01 2018-03-13 06998843 2018-03-13 06998843 core:RetainedEarningsAccumulatedLosses 2018-03-13 06998843 core:ShareCapital 2018-03-13 06998843 core:CurrentFinancialInstruments core:WithinOneYear 2018-03-13 06998843 core:Non-currentFinancialInstruments 2018-03-13 06998843 core:Non-currentFinancialInstruments core:AfterOneYear 2018-03-13 06998843 core:FurnitureFittingsToolsEquipment 2018-03-13 06998843 core:LandBuildings 2018-03-13 06998843 core:MotorVehicles 2018-03-13 06998843 bus:SmallEntities 2017-05-01 2018-03-13 06998843 bus:AuditExemptWithAccountantsReport 2017-05-01 2018-03-13 06998843 bus:FullAccounts 2017-05-01 2018-03-13 06998843 bus:SmallCompaniesRegimeForAccounts 2017-05-01 2018-03-13 06998843 bus:RegisteredOffice 2017-05-01 2018-03-13 06998843 bus:Director3 2017-05-01 2018-03-13 06998843 bus:Director4 2017-05-01 2018-03-13 06998843 bus:PrivateLimitedCompanyLtd 2017-05-01 2018-03-13 06998843 core:ComputerEquipment 2017-05-01 2018-03-13 06998843 core:FurnitureFittings 2017-05-01 2018-03-13 06998843 core:FurnitureFittingsToolsEquipment 2017-05-01 2018-03-13 06998843 core:LandBuildings 2017-05-01 2018-03-13 06998843 core:MotorVehicles 2017-05-01 2018-03-13 06998843 countries:AllCountries 2017-05-01 2018-03-13 06998843 2017-04-30 06998843 core:FurnitureFittingsToolsEquipment 2017-04-30 06998843 core:LandBuildings 2017-04-30 06998843 core:MotorVehicles 2017-04-30 06998843 2017-04-30 06998843 core:RetainedEarningsAccumulatedLosses 2017-04-30 06998843 core:ShareCapital 2017-04-30 06998843 core:CurrentFinancialInstruments core:WithinOneYear 2017-04-30 06998843 core:Non-currentFinancialInstruments 2017-04-30 06998843 core:Non-currentFinancialInstruments core:AfterOneYear 2017-04-30 06998843 core:FurnitureFittingsToolsEquipment 2017-04-30 06998843 core:LandBuildings 2017-04-30 06998843 core:MotorVehicles 2017-04-30 iso4217:GBP

Registration number: 06998843

Meds UK Limited

Annual Report and Unaudited Financial Statements

for the Period from 1 May 2017 to 13 March 2018

 

Meds UK Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3 to 8

 

Meds UK Limited

Company Information

Directors

R Masamha

T Masamha

Registered office

77 Westbourne Avenue
Princes Avenue
Hull
HU5 3HW

 

Meds UK Limited

(Registration number: 06998843)
Balance Sheet as at 13 March 2018

Note

13 March 2018
 £

30 April 2017
 £

Fixed assets

 

Tangible assets

4

14,001

740,554

Investments

5

-

2,769

 

14,001

743,323

Current assets

 

Stocks

32,842

85,340

Debtors

6

1,350,173

119,384

Cash at bank and in hand

 

793

10,108

 

1,383,808

214,832

Creditors: Amounts falling due within one year

7

(1,122,168)

(361,879)

Net current assets/(liabilities)

 

261,640

(147,047)

Total assets less current liabilities

 

275,641

596,276

Creditors: Amounts falling due after more than one year

7

-

(574,731)

Deferred tax liabilities

(2,660)

(22,175)

Net assets/(liabilities)

 

272,981

(630)

Capital and reserves

 

Called up share capital

1,000

1,000

Profit and loss account

271,981

(1,630)

Total equity

 

272,981

(630)

For the financial period ending 13 March 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 30 January 2019 and signed on its behalf by:
 

.........................................

T Masamha
Director

 

Meds UK Limited

Notes to the Financial Statements for the Period from 1 May 2017 to 13 March 2018

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
77 Westbourne Avenue
Princes Avenue
Hull
HU5 3HW
England

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

Meds UK Limited

Notes to the Financial Statements for the Period from 1 May 2017 to 13 March 2018

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures and fittings

15% on reducing balance

Motor vehicles

20% on reducing balance

Computer equipment

25% on reducing balance

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquiisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Meds UK Limited

Notes to the Financial Statements for the Period from 1 May 2017 to 13 March 2018

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

Meds UK Limited

Notes to the Financial Statements for the Period from 1 May 2017 to 13 March 2018

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

 

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was as follows:

1 May 2017 to 13 March 2018
 No.

Year ended 30 April 2017
 No.

Average number of employees

11

11

 

Meds UK Limited

Notes to the Financial Statements for the Period from 1 May 2017 to 13 March 2018

 

4

Tangible assets

Land and buildings
£

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost

At 1 May 2017

629,678

91,062

93,242

813,982

Additions

-

1,584

-

1,584

Disposals

(629,678)

(60,520)

(86,592)

(776,790)

At 13 March 2018

-

32,126

6,650

38,776

Depreciation

At 1 May 2017

-

46,535

26,893

73,428

Charge for the year

-

6,911

11,406

18,317

Eliminated on disposal

-

(30,925)

(36,045)

(66,970)

At 13 March 2018

-

22,521

2,254

24,775

Carrying amount

At 13 March 2018

-

9,605

4,396

14,001

At 30 April 2017

629,678

44,527

66,349

740,554

Included within the net book value of land and buildings above is £Nil (2017 - £629,678) in respect of freehold land and buildings.
 

 

5

Investments

2018
£

2017
£

Investments in racehorse syndicate

-

2,769

 

6

Debtors

13 March 2018
 £

30 April 2017
 £

Trade debtors

175,387

68,523

Other debtors

1,174,786

50,861

 

1,350,173

119,384

 

Meds UK Limited

Notes to the Financial Statements for the Period from 1 May 2017 to 13 March 2018

 

7

Creditors

Creditors: amounts falling due within one year

Note

13 March 2018
 £

30 April 2017
 £

Due within one year

 

Trade creditors

 

191,319

315,359

Social security and other taxes

 

95,162

17,074

Other creditors

 

835,687

29,446

 

1,122,168

361,879

Due after one year

 

Loans and borrowings

8

-

574,731

Creditors: amounts falling due after more than one year

Note

2018
£

2017
£

Due after one year

 

Loans and borrowings

8

-

574,731

 

8

Loans and borrowings

2018
£

2017
£

Non-current loans and borrowings

Bank borrowings

-

574,731